医学考博英语真题百度云https://docs.qq.com/doc/DT2VDZGF5YXpZUVlp
医学考博英语阅读的分值比重大，占整套试卷的30%，这部分的得分制约着总体得分。而相对于听力和写作题型，阅读理解是短期内容易提高并可以拿高分的题型。想要提高阅读理解做题正确率并拿高分，就需要了解医学阅读理解的特点。首先，就阅读的文章而言，其自身的特点是话题偏重医学科普方面的议论文和说明文，文章长度适中。而在题目设置方面，医学阅读也是有着一定的特点。
下面考博老师通过一篇真题的分析总结一些出题特点和应对思路供参考。
TheAmerican Society of Clinical Oncology wrapped its annual conference this week,going through the usual motions of presenting a lot of drugs that offer someadded quality or extension of life to those suffering from a variety of as-yetincurable diseases. But buried deep in an AP story are a couple of promisingheadlines that seems worthy of more thorough review, including one treatment study where 100 percent of patients saw theircancer diminish by half.
Firstof all, it seems pharmaceutical companies are moving away from the more cost-effectiveone-size-fits-all approach to drug development and embracing the long tail ofcancer treatments, engineering drugs that only work for a small percentage ofpatients but work very effectively within that group.
Pfizerannounced that one such drug it's pushing into late-stage testing is targetedfor 4% of lung cancer patients. But more than 90% of that tiny cohort respondedto the drug in initial tests, and nine out of ten is getting pretty close tothe ideal ten out of ten. By gearing drugs toward more boutique treatmentsrather than broad umbrella pharmaceuticals that try to fit for everyone itseems cancer researchers are making some headway. But how can we close the gapon that remaining ten percent?
AskTakeda Pharmaceutical and Celgene, two drug makers who put aside competitiveinterests to test a novel combination of their treatments. In a test of 66patients with the blood disease multiple myeloma, a full 100 percent of thesubjects saw their cancer reduced by half. Needless to say, a 100 percentresponse to a cancer drug (or in this case, a drug cocktail) is more or lessunheard of. Moreover, this combination never would've been tried if twocompeting companies hadn't sat down and put their heads together.
Arethere more potentially effective drug combos out there separated by walls of competitiveinterest and proprietary information? Who's to say, but it seems like with the vastamount of money and research being pumped into cancer drug development, the oddsare pretty good. And if researchers can start pushing more of their responsenumbers toward 100 percent, we can more easily start talking about oncology'sfavorite four-letter word: cure.
1. Which of the following can be the best titlefor the passage?
A.Competitionand Cooperation
B.TwoCompeting Pharmaceutical Companies
C.ThePromising Future of Pharmaceuticals
D.EncouragingNews: a 100% Response to a Cancer Drug
医学考博英语阅读的分值比重大，占整套试卷的30%，这部分的得分制约着总体得分。而相对于听力和写作题型，阅读理解是短期内容易提高并可以拿高分的题型。想要提高阅读理解做题正确率并拿高分，就需要了解医学阅读理解的特点。首先，就阅读的文章而言，其自身的特点是话题偏重医学科普方面的议论文和说明文，文章长度适中。而在题目设置方面，医学阅读也是有着一定的特点。
下面考博老师通过一篇真题的分析总结一些出题特点和应对思路供参考。
TheAmerican Society of Clinical Oncology wrapped its annual conference this week,going through the usual motions of presenting a lot of drugs that offer someadded quality or extension of life to those suffering from a variety of as-yetincurable diseases. But buried deep in an AP story are a couple of promisingheadlines that seems worthy of more thorough review, including one treatment study where 100 percent of patients saw theircancer diminish by half.
Firstof all, it seems pharmaceutical companies are moving away from the more cost-effectiveone-size-fits-all approach to drug development and embracing the long tail ofcancer treatments, engineering drugs that only work for a small percentage ofpatients but work very effectively within that group.
Pfizerannounced that one such drug it's pushing into late-stage testing is targetedfor 4% of lung cancer patients. But more than 90% of that tiny cohort respondedto the drug in initial tests, and nine out of ten is getting pretty close tothe ideal ten out of ten. By gearing drugs toward more boutique treatmentsrather than broad umbrella pharmaceuticals that try to fit for everyone itseems cancer researchers are making some headway. But how can we close the gapon that remaining ten percent?
AskTakeda Pharmaceutical and Celgene, two drug makers who put aside competitiveinterests to test a novel combination of their treatments. In a test of 66patients with the blood disease multiple myeloma, a full 100 percent of thesubjects saw their cancer reduced by half. Needless to say, a 100 percentresponse to a cancer drug (or in this case, a drug cocktail) is more or lessunheard of. Moreover, this combination never would've been tried if twocompeting companies hadn't sat down and put their heads together.
Arethere more potentially effective drug combos out there separated by walls of competitiveinterest and proprietary information? Who's to say, but it seems like with the vastamount of money and research being pumped into cancer drug development, the oddsare pretty good. And if researchers can start pushing more of their responsenumbers toward 100 percent, we can more easily start talking about oncology'sfavorite four-letter word: cure.
1. Which of the following can be the best titlefor the passage?
A.Competitionand Cooperation
B.TwoCompeting Pharmaceutical Companies
C.ThePromising Future of Pharmaceuticals
D.EncouragingNews: a 100% Response to a Cancer Drug
